Genpact director awarded 6,521 RSUs

Gangestad Nicholas C reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Gangestad Nicholas C reported acquisition or exercise transactions in this Form 4 filing.

Genpact LTD director Nicholas C. Gangestad received an equity grant in the form of restricted share units. He was awarded 6,521 unvested RSUs, each representing one common share at a future date, increasing his direct holdings to 15,334 common shares after the award.

The RSUs were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Subject to his continued service, the entire RSU award will vest on December 31, 2026 and will be settled in common shares on December 31, 2027, aligning his compensation further with long-term shareholder interests.

Insider Trade Summary

Grant/Award: 6,521 shares

Grant/Award 1 txn

Insider Gangestad Nicholas C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Shares	6,521	$0.00	$0.00

Holdings After Transaction: Common Shares — 15,334 shares (Direct)

Footnotes (1)

1. F1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Key Figures

RSU award size: 6,521 RSUs Post-award holdings: 15,334 shares Grant price per RSU: $0.0000 per unit +2 more

5 metrics

RSU award size 6,521 RSUs Unvested restricted share units granted to director

Post-award holdings 15,334 shares Common shares held directly after the RSU grant

Grant price per RSU $0.0000 per unit Indicates compensation award, not a cash purchase

Vesting date December 31, 2026 RSUs fully vest subject to continued service

Settlement date December 31, 2027 RSUs settled in Genpact common shares

Key Terms

restricted share units (RSUs), Genpact Limited 2017 Omnibus Incentive Compensation Plan, unvested restricted share units, settled in common shares

4 terms

restricted share units (RSUs) financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

Restricted share units (RSUs) are a form of employee pay where a company promises to give shares (or their cash value) to workers after certain conditions, usually time or performance, are met. For investors, RSUs matter because they can increase the number of shares outstanding and signal how management is being paid and incentivized—think of them as delayed bonuses that convert into ownership when vesting conditions are satisfied.

Genpact Limited 2017 Omnibus Incentive Compensation Plan financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

unvested restricted share units financial

"Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan."

settled in common shares financial

"the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Genpact (G) director Nicholas C. Gangestad receive in this transaction?

Nicholas C. Gangestad received an award of 6,521 unvested restricted share units. Each RSU represents the right to receive one Genpact common share in the future, providing equity-based compensation tied to his continued service with the company.

How many Genpact (G) shares does Nicholas C. Gangestad hold after this award?

After the RSU award, Nicholas C. Gangestad holds 15,334 common shares directly. This total reflects his position following the grant of 6,521 restricted share units, which are structured as equity compensation under Genpact’s 2017 Omnibus Incentive Compensation Plan.

When do Nicholas C. Gangestad’s Genpact RSUs vest and settle?

The 6,521 restricted share units fully vest on December 31, 2026, assuming continued service. They are then scheduled to be settled in Genpact common shares on December 31, 2027, creating a one-year gap between vesting and share delivery for the director.

What plan governs the RSU grant to Genpact (G) director Nicholas C. Gangestad?

The restricted share units were granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. This plan provides equity-based awards, such as RSUs, to align participants’ interests with the long-term performance and value of Genpact’s common shares.

Does Nicholas C. Gangestad pay a purchase price for these Genpact RSUs?

The RSUs were granted with a transaction price of $0.0000 per unit, indicating no cash purchase price. They function as a compensation award, delivering Genpact common shares at future dates if the director continues his service through the vesting schedule.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/27/2026 - 04:24 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gangestad Nicholas C

(Last) (First) (Middle)

C/O GENPACT LLC

521 FIFTH AVENUE, 14TH FLOOR

(Street)

NEW YORK NEW YORK 10175

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Genpact LTD [ G ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	04/23/2026		A		6,521(1)	A	$0	15,334	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of unvested restricted share units (RSUs) granted under the Genpact Limited 2017 Omnibus Incentive Compensation Plan. Each RSU entitles the holder to receive one common share at a future date. Subject to the reporting person's continued service, the RSUs will fully vest on December 31, 2026 and will be settled in common shares on December 31, 2027.

Remarks:

	/s/ Thomas D. Scholtes, as Attorney-in-fact for Nicholas C. Gangestad	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)